Literature DB >> 30842029

Visual hallucinations associated with multimodal hallucinations, suicide attempts and morbidity of illness in psychotic disorders.

Virginie-Anne Chouinard1, Ann K Shinn2, Linda Valeri3, Philippe A Chouinard4, Margaret E Gardner5, A Esin Asan5, Bruce M Cohen2, Dost Öngür2.   

Abstract

BACKGROUND: Visual hallucinations (VH) are a common, but understudied symptom of psychosis, experienced by individuals across diagnostic categories of psychotic and neuropsychiatric conditions. There are limited data on VH and associated clinical phenotypes in adult idiopathic psychotic disorders, which are needed to elucidate their relevance to psychotic illness paradigms.
METHOD: In this cross-sectional study, we examined clinical risk factors for VH in a well-characterized sample of 766 patients with adult psychotic disorders across diagnostic categories of schizophrenia (n = 227), schizoaffective disorder (n = 210), and bipolar I disorder (n = 329). The Structured Clinical Interview for DSM-IV-TR was used for diagnosis and symptom measurements.
RESULTS: The prevalence of VH was 26.1% (200/766). Multivariate logistic regression showed that VH were independently associated with the presence of hallucinations in other modalities, including auditory, tactile, olfactory, and gustatory hallucinations. History of a suicide attempt and catatonic behavior were also associated with VH. In addition, specific delusions were associated with VH, in particular, delusions of control, and religious, erotomanic and jealousy delusions. Diagnosis, negative symptoms, and family history of psychosis were not independent predictors of VH.
CONCLUSIONS: Results showed the clinical and disease relevance of VH as they were associated with severe morbidity of illness, including suicide attempts and catatonic behavior. Findings also suggest a phenotype associated with hallucinations in other modalities and specific types of delusions. Based on our findings, VH may be a significant factor in assessing for suicidality and illness severity, warranting clinical attention and further study of underlying mechanisms.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Hallucinations; Schizoaffective; Schizophrenia; Visual

Mesh:

Year:  2019        PMID: 30842029      PMCID: PMC6664439          DOI: 10.1016/j.schres.2019.02.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  44 in total

1.  Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.

Authors:  Thomas Insel; Bruce Cuthbert; Marjorie Garvey; Robert Heinssen; Daniel S Pine; Kevin Quinn; Charles Sanislow; Philip Wang
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

2.  Suicidality and hospitalisation in patients with borderline personality disorder who experience auditory verbal hallucinations.

Authors:  C W Slotema; M B A Niemantsverdriet; J D Blom; M van der Gaag; H W Hoek; I E C Sommer
Journal:  Eur Psychiatry       Date:  2017-02-03       Impact factor: 5.361

3.  Rubber hands 'feel' touch that eyes see.

Authors:  M Botvinick; J Cohen
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

4.  Testing an aetiological model of visual hallucinations in Parkinson's disease.

Authors:  David A Gallagher; Laura Parkkinen; Sean S O'Sullivan; Alexander Spratt; Ameet Shah; Clare C Davey; Fion D Bremner; Tamas Revesz; David R Williams; Andrew J Lees; Anette Schrag
Journal:  Brain       Date:  2011-09-15       Impact factor: 13.501

5.  Hallucinations in bipolar disorder: characteristics and comparison to unipolar depression and schizophrenia.

Authors:  Christopher Baethge; Ross J Baldessarini; Klaus Freudenthal; Anna Streeruwitz; Michael Bauer; Tom Bschor
Journal:  Bipolar Disord       Date:  2005-04       Impact factor: 6.744

Review 6.  Pimavanserin: novel pharmacotherapy for Parkinson's disease psychosis.

Authors:  Zeyad T Sahli; Frank I Tarazi
Journal:  Expert Opin Drug Discov       Date:  2017-10-31       Impact factor: 6.098

7.  The multimodal connectivity of the hippocampal complex in auditory and visual hallucinations.

Authors:  A Amad; A Cachia; P Gorwood; D Pins; C Delmaire; B Rolland; M Mondino; P Thomas; R Jardri
Journal:  Mol Psychiatry       Date:  2013-01-15       Impact factor: 15.992

Review 8.  Epidemiology of psychosis in Parkinson's disease.

Authors:  Gilles Fénelon; Guido Alves
Journal:  J Neurol Sci       Date:  2009-09-08       Impact factor: 3.181

9.  Tactile, olfactory, and gustatory hallucinations in psychotic disorders: a descriptive study.

Authors:  Kathryn E Lewandowski; Joseph DePaola; Gamze B Camsari; Bruce M Cohen; Dost Ongür
Journal:  Ann Acad Med Singapore       Date:  2009-05       Impact factor: 2.473

10.  Neural correlates of natural human echolocation in early and late blind echolocation experts.

Authors:  Lore Thaler; Stephen R Arnott; Melvyn A Goodale
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

View more
  4 in total

Review 1.  An Integrated Neuroimaging Approach to Inform Transcranial Electrical Stimulation Targeting in Visual Hallucinations.

Authors:  Nicolas Raymond; Robert M G Reinhart; Matcheri Keshavan; Paulo Lizano
Journal:  Harv Rev Psychiatry       Date:  2022 May-Jun 01       Impact factor: 3.868

2.  The Strasbourg Visual Scale: A Novel Method to Assess Visual Hallucinations.

Authors:  Anne Giersch; Thomas Huard; Sohee Park; Cherise Rosen
Journal:  Front Psychiatry       Date:  2021-06-09       Impact factor: 4.157

Review 3.  The Phenomenology and Neurobiology of Visual Distortions and Hallucinations in Schizophrenia: An Update.

Authors:  Steven M Silverstein; Adriann Lai
Journal:  Front Psychiatry       Date:  2021-06-11       Impact factor: 4.157

4.  A psychological intervention for suicide applied to non-affective psychosis: the CARMS (Cognitive AppRoaches to coMbatting Suicidality) randomised controlled trial protocol.

Authors:  Patricia A Gooding; Daniel Pratt; Yvonne Awenat; Richard Drake; Rachel Elliott; Richard Emsley; Charlotte Huggett; Steven Jones; Navneet Kapur; Fiona Lobban; Sarah Peters; Gillian Haddock
Journal:  BMC Psychiatry       Date:  2020-06-16       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.